Neuroscience / With one of the strongest pipelines in the industry, Roche Neuroscience is developing medicines for a range of serious brain diseases, including schizophrenia, Alzheimer’s disease, multiple sclerosis, depression, Parkinson’s disease, Down syndrome and autism.
http://www.roche.com